Vaginal estrogen therapy utilization and associated outcomes in younger survivors of endometrial cancer

Key Points

• Investigate the impact of vaginal estrogen therapy on recurrence rates in younger endometrial cancer survivors.
• Evaluated endometrial cancer survivors
• Compared recurrence rates between those using vaginal estrogen and those not using it
• Assessed short-term exposure effects
• No significant increase in cancer recurrence was found in those exposed to vaginal estrogen therapy
• Short-term vaginal estrogen therapy appears safe for younger survivors

Abstract